Literature DB >> 30369732

Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern.

Bharani Vani1, Aggarwal Ritu2, Sharma Praveen3, Malhotra Pankaj4, Ranjana Minz2.   

Abstract

Serum and urine protein electrophoresis and immunofixation are essential for identification and categorization of M protein/monoclonal protein. Based on the number of discrete bands identified the condition can be a monoclonal, biclonal or triclonal gammopathy. A subset of cases show an interesting pattern on immunofixation electrophoresis, with a complete immunoglobulin molecule, along with excess free light chains where in one light chain band shows similar mobility as the heavy chain, while the other light chain band of same isotype has a different mobility. Over a 3 year study period, 420 immunofixation electrophoresis gels were studied to select the cases with the typical pattern as described. The clinical records where searched for data of baseline evaluations done prior to starting therapy, including clinical presentation, biochemical parameters, hemogram and bone marrow examination. Twenty cases (4.7%) were identified from the records, of these 77.8% cases had renal impairment and 33.3% presented with rapidly progressive renal failure. The possible explanation is the toxic effects of excess free light chains, in our cohort. The bound LCs show mobility similar to the HC bands on serum immunofixation gels, however the free light chains, exist in polymeric forms and show a different mobility. The identification and reporting of this pattern provides additional information regarding the high load of light chains, and indicates that patient may have a poor renal outcome/performance.

Entities:  

Keywords:  Free light chains; Immunofixation electrophoresis; Monoclonal band; Multiple myeloma

Year:  2018        PMID: 30369732      PMCID: PMC6186226          DOI: 10.1007/s12288-018-0926-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  12 in total

Review 1.  Management of paraproteinaemia.

Authors:  Lucy Cook; Donald H C Macdonald
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

2.  Clinical characteristics of a group of patients with multiple myeloma who had two different λ light chains by immunofixation electrophoresis: A retrospective study from a single center.

Authors:  Guangzhong Yang; Chuanying Geng; Wenming Chen
Journal:  Exp Ther Med       Date:  2015-03-13       Impact factor: 2.447

Review 3.  Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma.

Authors:  Aroonima Misra; Jyoti Mishra; Jagan Chandramohan; Atul Sharma; Vinod Raina; Rajive Kumar; Sushant Soni; Anita Chopra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-13       Impact factor: 0.900

4.  Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

Authors:  L M Knudsen; M Hjorth; E Hippe
Journal:  Eur J Haematol       Date:  2000-09       Impact factor: 2.997

5.  Polymeric forms of free light chains in serum from normal individuals and from patients with renal diseases.

Authors:  K Sölling
Journal:  Scand J Clin Lab Invest       Date:  1976-09       Impact factor: 1.713

6.  The clinical aspects of biclonal gammopathies. Review of 57 cases.

Authors:  R A Kyle; R A Robinson; J A Katzmann
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

7.  Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols.

Authors:  Bijay Nair; Sarah Waheed; Jackie Szymonifka; John D Shaughnessy; John Crowley; Bart Barlogie
Journal:  Br J Haematol       Date:  2008-12-20       Impact factor: 6.998

8.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

9.  Clinical characteristics and outcomes in biclonal gammopathies.

Authors:  Trey C Mullikin; S Vincent Rajkumar; Angela Dispenzieri; Francis K Buadi; Martha Q Lacy; Yi Lin; David Dingli; Ronald S Go; Suzanne R Hayman; Steven R Zeldenrust; Stephen J Russell; John A Lust; Nelson Leung; Prashant Kapoor; Robert A Kyle; Morie A Gertz; Shaji K Kumar
Journal:  Am J Hematol       Date:  2016-04-06       Impact factor: 10.047

Review 10.  Immunoglobulin free light chain dimers in human diseases.

Authors:  Batia Kaplan; Avi Livneh; Ben-Ami Sela
Journal:  ScientificWorldJournal       Date:  2011-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.